A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Dan Evans has caused another shock at the Australian Open by beating Bernard Tomic to reach the last 16.
Fighters blew up Palmyra's Tetrapylon and the facade of its Roman Theatre, according to Syrian antiquities chief Maamoun Abdulkarim.
The 40-year-old man was working at the Khalifa International Stadium which is being renovated ahead of the 2022 World Cup.